Datavault AI (NASDAQ: DVLT) announced an expansion of its definitive licensing agreement with DataMeds AI Inc., extending its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement aims to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. This leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies stated that the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models. This expansion signifies a strategic move to capitalize on the growing intersection of blockchain, AI, and healthcare data management.
Datavault AI’s platform integrates its Data Science division, which leverages Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. The company’s technology suite includes the Information Data Exchange, which enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata. This fosters responsible AI with integrity, and the platform is customizable with AI- and machine-learning-based automation, third-party integration, detailed analytics, and marketing automation.
The expanded agreement positions Datavault AI to address the increasing demand for secure, patient-controlled health data management. As healthcare continues to digitize, the ability for patients to control and monetize their own data becomes critical. The partnership with DataMEDS AI Inc. aims to create new revenue streams for patients and healthcare providers alike, while ensuring data integrity through blockchain technology. The move also reflects broader industry trends toward tokenization of real-world assets and decentralized data management.
For more details, the full press release is available at https://ibn.fm/vBAxH. Information about Datavault AI can be found at https://dvlt.ai.
